Correction: Longitudinal association of peripheral blood DNA methylation with liver fat content: distinguishing between predictors and biomarkers.
作者信息
Zeng Hailuan, Li Wenran, Xia Mingfeng, Ge Jieyu, Ma Hui, Chen Lingyan, Pan Baishen, Lin Huandong, Wang Sijia, Gao Xin
机构信息
Department of Endocrinology and Metabolism, Zhongshan Hospital, Fudan University, NO. 180 Fenglin Road, Shanghai, 200032, China.
Fudan Institute for Metabolic Diseases, Shanghai, China.
出版信息
Lipids Health Dis. 2024 Dec 17;23(1):400. doi: 10.1186/s12944-024-02405-5.
Abstract
摘要
相似文献
1
Correction: Longitudinal association of peripheral blood DNA methylation with liver fat content: distinguishing between predictors and biomarkers.更正：外周血DNA甲基化与肝脏脂肪含量的纵向关联：区分预测指标和生物标志物。
Lipids Health Dis. 2024 Dec 17;23(1):400. doi: 10.1186/s12944-024-02405-5.
2
Longitudinal association of peripheral blood DNA methylation with liver fat content: distinguishing between predictors and biomarkers.外周血 DNA 甲基化与肝脂肪含量的纵向关联：预测因子和生物标志物的区分。
Lipids Health Dis. 2024 Sep 27;23(1):309. doi: 10.1186/s12944-024-02304-9.
3
DNA methylation age acceleration contributes to the development and prediction of non-alcoholic fatty liver disease.DNA 甲基化年龄加速与非酒精性脂肪性肝病的发生和预测有关。
Geroscience. 2024 Aug;46(4):3525-3542. doi: 10.1007/s11357-023-00903-5. Epub 2023 Aug 22.
4
A Peripheral Blood DNA Methylation Signature of Hepatic Fat Reveals a Potential Causal Pathway for Nonalcoholic Fatty Liver Disease.外周血 DNA 甲基化特征可揭示非酒精性脂肪肝的潜在因果途径
Diabetes. 2019 May;68(5):1073-1083. doi: 10.2337/DB18-1193. Epub 2019 Apr 1.
5
The association of DNA methylation with body mass index: distinguishing between predictors and biomarkers.DNA 甲基化与体重指数的关联：区分预测因子和生物标志物。
Clin Epigenetics. 2020 Mar 30;12(1):50. doi: 10.1186/s13148-020-00841-5.
6
DNA methylation biomarkers for diagnosis of primary liver cancer and distinguishing hepatocellular carcinoma from intrahepatic cholangiocarcinoma.用于原发性肝癌诊断和区分肝细胞癌与肝内胆管细胞癌的 DNA 甲基化生物标志物。
Aging (Albany NY). 2021 Jul 8;13(13):17592-17606. doi: 10.18632/aging.203249.
7
Harnessing peripheral DNA methylation differences in the Alzheimer's Disease Neuroimaging Initiative (ADNI) to reveal novel biomarkers of disease.利用阿尔茨海默病神经影像学倡议（ADNI）中的外周 DNA 甲基化差异来揭示疾病的新型生物标志物。
Clin Epigenetics. 2020 Jun 15;12(1):84. doi: 10.1186/s13148-020-00864-y.
8
Investigating peripheral blood monocyte and T-cell subsets as non-invasive biomarkers for asymptomatic hepatic steatosis: results from the Multi-Ethnic Study of Atherosclerosis.探讨外周血单核细胞和 T 细胞亚群作为无症状性肝脂肪变性的非侵入性生物标志物：来自动脉粥样硬化多民族研究的结果。
Front Immunol. 2024 Mar 26;15:1243526. doi: 10.3389/fimmu.2024.1243526. eCollection 2024.
9
Significant differences in global genomic DNA methylation by gender and race/ethnicity in peripheral blood.性别和种族/民族对外周血全基因组 DNA 甲基化的显著影响。
Epigenetics. 2011 May;6(5):623-9. doi: 10.4161/epi.6.5.15335.
10
Systematic review of lung function and COPD with peripheral blood DNA methylation in population based studies.基于人群研究的肺功能和慢性阻塞性肺疾病与外周血DNA甲基化的系统评价。
BMC Pulm Med. 2017 Mar 20;17(1):54. doi: 10.1186/s12890-017-0397-3.
本文引用的文献
1
Longitudinal association of peripheral blood DNA methylation with liver fat content: distinguishing between predictors and biomarkers.外周血 DNA 甲基化与肝脂肪含量的纵向关联：预测因子和生物标志物的区分。
Lipids Health Dis. 2024 Sep 27;23(1):309. doi: 10.1186/s12944-024-02304-9.
Zotero 插件